Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.

Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Liggitt D, Eaton KD, Martins R, Poirier JT, Rudin CM, Milletti F, Cheng WY, Mack F, MacPherson D.

Sci Signal. 2019 Feb 5;12(567). pii: eaau2922. doi: 10.1126/scisignal.aau2922.

PMID:
30723171
2.

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.

Romine PE, Martins RG, Eaton KD, Wood DE, Behnia F, Goulart BHL, Mulligan MS, Wallace SG, Kell E, Bauman JE, Patel SA, Vesselle HJ.

BMC Cancer. 2019 Jan 14;19(1):70. doi: 10.1186/s12885-019-5284-2.

3.

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia.

Romine PE, Eaton KD, Paulson KG, Hadi R, Paauw DS.

Am J Med. 2019 Jan;132(1):e13-e14. doi: 10.1016/j.amjmed.2018.09.009. Epub 2018 Sep 19. No abstract available.

PMID:
30240678
4.

Characterizing Potentially Preventable Cancer- and Chronic Disease-Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study.

Panattoni L, Fedorenko C, Greenwood-Hickman MA, Kreizenbeck K, Walker JR, Martins R, Eaton KD, Rieke JW, Conklin T, Smith B, Lyman G, Ramsey SD.

J Oncol Pract. 2018 Mar;14(3):e176-e185. doi: 10.1200/JOP.2017.028191. Epub 2018 Feb 8.

PMID:
29452549
5.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Eaton KD, Romine PE, Goodman GE, Thornquist MD, Barnett MJ, Petersdorf EW.

J Thorac Oncol. 2018 May;13(5):649-659. doi: 10.1016/j.jtho.2018.01.022. Epub 2018 Mar 23.

PMID:
29408308
6.

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors.

King GT, Eaton KD, Beagle BR, Zopf CJ, Wong GY, Krupka HI, Hua SY, Messersmith WA, El-Khoueiry AB.

Invest New Drugs. 2018 Oct;36(5):836-847. doi: 10.1007/s10637-018-0560-6. Epub 2018 Jan 15.

PMID:
29333575
7.

Pregnancy Screening in Patients With Cancer.

Gustafson AM, Goldfrank DJ, Dunson WA, Mulkerin DL, Caires RL, Eaton KD.

J Natl Compr Canc Netw. 2018 Jan;16(1):99-103. doi: 10.6004/jnccn.2017.7059. No abstract available.

PMID:
29295884
8.

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies.

Rodriguez CP, Martins RG, Baik C, Chow LQ, Santana-Davila R, Goulart BH, Lee S, Eaton KD.

Head Neck. 2018 Mar;40(3):584-589. doi: 10.1002/hed.25020. Epub 2017 Dec 28.

PMID:
29283469
9.

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).

Awad MM, Chu QS, Gandhi L, Stephenson JJ, Govindan R, Bradford DS, Bonomi PD, Ellison DM, Eaton KD, Fritsch H, Munzert G, Johnson BE, Socinski MA.

Lung Cancer. 2017 Feb;104:126-130. doi: 10.1016/j.lungcan.2016.12.019. Epub 2016 Dec 30.

PMID:
28212994
10.

Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.

Pellini Ferreira B, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R, Rodriguez CP.

Laryngoscope. 2017 Jul;127(7):1583-1588. doi: 10.1002/lary.26422. Epub 2016 Dec 1.

PMID:
27905113
11.

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.

Chow LQM, Morishima C, Eaton KD, Baik CS, Goulart BH, Anderson LN, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM, Disis ML, Martins RG.

Clin Cancer Res. 2017 May 15;23(10):2442-2450. doi: 10.1158/1078-0432.CCR-16-1934. Epub 2016 Nov 3.

12.

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer.

Ou SI, Govindan R, Eaton KD, Otterson GA, Gutierrez ME, Mita AC, Argiris A, Brega NM, Usari T, Tan W, Ho SN, Robert F.

J Thorac Oncol. 2017 Jan;12(1):145-151. doi: 10.1016/j.jtho.2016.09.131. Epub 2016 Sep 30.

13.

Value-Based Care in Lung Cancer.

Eaton KD, Jagels B, Martins RG.

Oncologist. 2016 Aug;21(8):903-6. doi: 10.1634/theoncologist.2016-0116. Epub 2016 Jun 2. No abstract available.

14.

Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.

Dang J, Feng Q, Eaton KD, Jang H, Kiviat NB.

BMC Oral Health. 2015 Oct 15;15(1):126. doi: 10.1186/s12903-015-0111-x.

15.

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juhász E, Ramlau R, van den Heuvel MM, Lal R, Kloecker GH, Eaton KD, Chu Q, Dunlop DJ, Jain M, Garon EB, Davis CS, Carrier E, Moses SC, Shawler DL, Fakhrai H.

Eur J Cancer. 2015 Nov;51(16):2321-9. doi: 10.1016/j.ejca.2015.07.035. Epub 2015 Aug 14.

PMID:
26283035
16.

The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.

Tailor TD, Schmidt RA, Eaton KD, Wood DE, Pipavath SN.

J Thorac Imaging. 2015 Sep;30(5):308-13. doi: 10.1097/RTI.0000000000000168.

PMID:
26258598
17.

Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.

Fang M, Becker PS, Linenberger M, Eaton KD, Appelbaum FR, Dreyer Z, Airewele G, Redell M, Lopez-Terrada D, Patel A, Rabin KR, Lu X.

Am J Clin Pathol. 2015 Aug;144(2):263-70. doi: 10.1309/AJCPW83OXPYKPEEN.

PMID:
26185311
18.

Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.

Mellati M, Eaton KD, Brooks-Worrell BM, Hagopian WA, Martins R, Palmer JP, Hirsch IB.

Diabetes Care. 2015 Sep;38(9):e137-8. doi: 10.2337/dc15-0889. Epub 2015 Jun 26. No abstract available.

PMID:
26116720
19.

Spontaneous regression of non-small-cell lung cancer in AIDS after immune reconstitution.

Menon MP, Eaton KD.

J Thorac Oncol. 2015 Jan;10(1):e1-2. doi: 10.1097/JTO.0000000000000236. No abstract available.

20.

Occult primary, version 3.2014.

Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):969-74.

PMID:
24994917
21.

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A, Liu Y, Eaton KD, Martins R, Stricker K, Margolin KA, Hoffman N, Churpek JE, Tait JF, King MC, Walsh T.

J Mol Diagn. 2014 Jan;16(1):56-67. doi: 10.1016/j.jmoldx.2013.08.004. Epub 2013 Nov 2.

22.

Plasma processing conditions substantially influence circulating microRNA biomarker levels.

Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, Goodman MT, Tait JF, Tewari M, Pritchard CC.

PLoS One. 2013 Jun 7;8(6):e64795. doi: 10.1371/journal.pone.0064795. Print 2013.

23.

Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.

Martins RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ, Mendez E, Futran N, Wang DX, Chai X, Wallace SG, Austin M, Schmidt R, Hayes DN.

J Clin Oncol. 2013 Apr 10;31(11):1415-21. doi: 10.1200/JCO.2012.46.3299. Epub 2013 Mar 4.

PMID:
23460709
24.

EGFR mutations in squamous cell lung cancer in never-smokers.

Baik CS, Pritchard CC, Eaton KD, Chow LQ.

J Thorac Oncol. 2013 Jan;8(1):e6-7. doi: 10.1097/JTO.0b013e3182762d49. No abstract available.

25.

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.

Bauman JE, Eaton KD, Wallace SG, Carr LL, Lee SJ, Jones DV, Arias-Pulido H, Cerilli LA, Martins RG.

BMC Cancer. 2012 Oct 3;12:449. doi: 10.1186/1471-2407-12-449.

26.

A 66-year-old woman with newly diagnosed oligometastatic non-small cell lung cancer.

Shiovitz S, Eaton KD.

J Natl Compr Canc Netw. 2012 Mar;10(3):297-301.

PMID:
22393191
27.

Estrogen signaling in lung cancer: an opportunity for novel therapy.

Baik CS, Eaton KD.

Cancers (Basel). 2012 Sep 25;4(4):969-88. doi: 10.3390/cancers4040969.

28.

Radiation-induced myelopathy: treatment with bevacizumab.

Chamberlain MC, Eaton KD, Fink J.

Arch Neurol. 2011 Dec;68(12):1608-9. doi: 10.1001/archneurol.2011.621. No abstract available.

PMID:
22159063
29.

NCCN Clinical Practice Guidelines Occult primary.

Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WK; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Dec;9(12):1358-95.

PMID:
22157556
30.

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.

Carr LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.

Clin Cancer Res. 2010 Nov 1;16(21):5260-8. doi: 10.1158/1078-0432.CCR-10-0994. Epub 2010 Sep 16.

31.

Maintenance chemotherapy in non-small cell lung cancer.

Eaton KD, Martins RG.

J Natl Compr Canc Netw. 2010 Jul;8(7):815-21. Review.

PMID:
20679540
32.

Intradural intramedullary spinal cord metastasis due to mesothelioma.

Chamberlain MC, Eaton KD, Fink JR, Tredway T.

J Neurooncol. 2010 Mar;97(1):133-6. doi: 10.1007/s11060-009-9995-0. Epub 2009 Aug 20.

PMID:
19693437
33.

Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.

Bauman JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.

Ann Thorac Surg. 2008 Nov;86(5):1632-8; discussion 1638-9. doi: 10.1016/j.athoracsur.2008.07.042.

PMID:
19049763
34.

Cancer pain: perspectives of a medical oncologist.

Eaton KD, Frieze DA.

Curr Pain Headache Rep. 2008 Aug;12(4):270-6. Review.

PMID:
18625104
35.

Antagonism of platelet-derived growth factor receptor in non small cell lung cancer: rationale and investigations.

Bauman JE, Eaton KD, Martins RG.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4632-6. Review.

36.

Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Bauman JE, Eaton KD, Martins RG.

Arch Dermatol. 2007 Jul;143(7):889-92.

PMID:
17638733
37.

Transition between curved and angular textures in binary fluid convection.

La Porta A, Eaton KD, Surko CM.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1996 Jan;53(1):570-576. No abstract available.

PMID:
9964287
38.

Eckhaus instability for traveling waves.

Baxter GW, Eaton KD, Surko CM.

Phys Rev A. 1992 Aug 15;46(4):R1735-R1738. No abstract available.

PMID:
9908373
39.

Concentration field in traveling-wave and stationary convection in fluid mixtures.

Eaton KD, Ohlsen DR, Yamamoto SY, Surko CM, Barten W, Lücke M, Kamps M, Kolodner P.

Phys Rev A. 1991 Jun 15;43(12):7105-7108. No abstract available.

PMID:
9905075

Supplemental Content

Loading ...
Support Center